BUCHI J KEVIN — SEC insider filings
SEC reporting owner CIK 1209726. 31 insider filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2020-10-13 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 5 filings — 198,671 shares, $38,978 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: purchase of 44,026 shares @ $0.25 ($10,857) in Ampio Pharmaceuticals, Inc., filed 2023-05-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ampio Pharmaceuticals, Inc. (AMPE) | Director | 6 | 5 legs · 146,858 sh · $38,978 | — | 2 |
| Benitec Biopharma Inc. (BNTC) | Director | 10 | 1 leg · 51,813 sh | — | 12 |
| Amneal Pharmaceuticals, Inc. (AMRX) | Director | 11 | — | — | 23 |
| Dicerna Pharmaceuticals Inc (DRNA) | Director | 2 | — | — | 11 |
| ZIOPHARM ONCOLOGY INC (ZIOP) | Director | 2 | — | — | 3 |
Insider filings — BUCHI J KEVIN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Gift (G): 20,445 @ $0 | EDGAR |
| 2026-09-14 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 20,445 @ $14.45 · Option exercise (M): 20,445 (derivative) @ $0 | EDGAR |
| 2026-08-13 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 168,573 @ $17.18 | EDGAR |
| 2026-06-30 | 4 | Benitec Biopharma Inc. (BNTC) | Gift (G): 51,813 @ $0 | EDGAR |
| 2026-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 34,819 · Option exercise (M): 34,819 (derivative) @ $0 · Grant/award (A): 19,824 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | Benitec Biopharma Inc. (BNTC) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 40,258 · Option exercise (M): 40,258 (derivative) @ $0 · Grant/award (A): 34,819 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Benitec Biopharma Inc. (BNTC) | Gift (G): 103,626 @ $0 · Gift (G): 103,626 @ $0 | EDGAR |
| 2025-03-12 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Gift (G): 262,072 @ $0 | EDGAR |
| 2025-03-03 | 4 | Benitec Biopharma Inc. (BNTC) | Option exercise (M): 51,813 @ $3.86 · Option exercise (M): 51,813 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Benitec Biopharma Inc. (BNTC) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 76,453 · Option exercise (M): 76,453 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 40,258 (derivative) @ $0 | EDGAR |
| 2023-12-07 | 4 | Benitec Biopharma Inc. (BNTC) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-08-14 | 4 | Benitec Biopharma Inc. (BNTC) | Purchase (P): 51,813 · Purchase (P): 51,813 (derivative) | EDGAR |
| 2023-06-13 | 4 | Ampio Pharmaceuticals, Inc. (AMPE) | Purchase (P): 21,858 @ $0.29 | EDGAR |
| 2023-06-09 | 4 | Ampio Pharmaceuticals, Inc. (AMPE) | Purchase (P): 25,000 @ $0.30 | EDGAR |
| 2023-05-17 | 4 | Ampio Pharmaceuticals, Inc. (AMPE) | Purchase (P): 32,534 @ $0.27 | EDGAR |
| 2023-05-16 | 4 | Ampio Pharmaceuticals, Inc. (AMPE) | Purchase (P): 23,440 @ $0.24 · Purchase (P): 44,026 @ $0.25 | EDGAR |
| 2023-05-11 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 80,128 · Grant/award (A): 76,453 (derivative) @ $0 · Option exercise (M): 80,128 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Benitec Biopharma Inc. (BNTC) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2022-05-10 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 35,406 · Option exercise (M): 35,406 (derivative) @ $0 · Grant/award (A): 80,128 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | Ampio Pharmaceuticals, Inc. (AMPE) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2021-12-29 | 4 | Dicerna Pharmaceuticals Inc (DRNA) | Code (U): 4,666 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · +1 more | EDGAR |
| 2021-12-10 | 4 | Benitec Biopharma Inc. (BNTC) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2021-10-25 | 4 | Ampio Pharmaceuticals, Inc. (AMPE) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | Dicerna Pharmaceuticals Inc (DRNA) | Option exercise (M): 4,666 · Option exercise (M): 4,666 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-05-07 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 46,218 · Grant/award (A): 35,406 (derivative) @ $0 · Option exercise (M): 46,218 (derivative) @ $0 | EDGAR |
| 2021-05-06 | 4 | ZIOPHARM ONCOLOGY INC (ZIOP) | Grant/award (A): 4,167 @ $0 · Grant/award (A): 31,250 (derivative) @ $0 | EDGAR |
| 2020-12-11 | 4 | Benitec Biopharma Inc. (BNTC) | Grant/award (A): 23,601 (derivative) @ $0 | EDGAR |
| 2020-10-13 | 4 | ZIOPHARM ONCOLOGY INC (ZIOP) | Grant/award (A): 146,190 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1209726 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs